Tuesday, December 15, 2020
A. Federal Trade Commission (FTC)
Consent decree for Stryker Corp. to divest assets as part of $4 billion acquisition of Wright Medical Group N.V.
On Nov. 3, 2020, the FTC announced that it would require Stryker Corp. and Wright Medical Group N.V. to divest assets related to Stryker’s total ankle replacements and finger joint implant products to remedy antitrust concerns that Stryker’s proposed $4 billion acquisition of Wright would harm competition in those markets. The FTC consent decree requires the divestiture of those assets to DJO Global, Inc., permitting it to become an independent, viable, and effective competitor to Stryker. The proposed consent decree also requires Stryker to supply DJO Global with transition assistance and to act as an intermediary supplier until DJO Global obtains FDA approval to be the legal manufacturer of the divested products